AETN · Aeternum Health, Inc.
$0.16
-0.01 (-5.88%)
At close · Sep 2
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued.”View the 10-Q filed Aug 19, 2026
Market Cap
$15.54M
Shares
97.11M
AETN metrics
40 of 114 screener metrics currently available.
Market overview
2 metricsShare price
$0.16
Market cap
$15.54M
Price action
19 metricsPrice change (1W)
+6.3%
Price change (30D)
+54.5%
Price change (3M)
+71.7%
Price change (6M)
+3.0%
Price change (YTD)
+415.2%
Price change (1Y)
+580.0%
Trailing year
Price change (5Y)
-69.1%
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
362.6%
Beta
1.0
RSI (14D)
55.8
Price vs SMA 50
+39.3%
Price vs SMA 200
+94.9%
Avg volume (3M)
33,882
Relative volume
0.9
Average dollar volume
$4,249
Company
3 metricsSector
Consumer Cyclical
Industry
Specialty Retail
Shares outstanding
97.11M
Valuation
12 metricsP / E (TTM)
17.0
Trailing earnings · reciprocal yield 5.9%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
376.6×
reciprocal yield 0.3%
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
8.7%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
-41.9%
Operating margin
-132.2%
Trailing 12 months
Net margin
-165.5%
Gross profit (TTM)
−$17,275
Operating profit (TTM)
−$593,724
Net income (TTM)
$1.35M
Trailing 12 months
Diluted EPS (TTM)
$0.01
FCF margin
—
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
-98.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$41,258
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+11.1%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
69.8%
Debt / equity
—
Current ratio
—
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
—
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$0
Total assets
$1.93M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$1.58M
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$4,125
R&D / revenue
—
Stock compensation / revenue
—
Ownership (13F)
3 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Short interest
3 metricsShort interest
—
Latest settlement
Days to cover
—
Short-squeeze score
—
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
Flagged